Related Experiment Video
Updated: Aug 12, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Bioinformatic analysis of microRNA expression in Huntington's disease
1Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.
Insights
This study identifies a pattern of microRNAs (miRNAs) involved in Huntington's disease (HD) pathogenesis. Key miRNAs like hsa‑miR‑4488, hsa‑miR‑196a‑5p, and hsa‑miR‑549a show potential as therapeutic targets for this inherited neurodegenerative disorder.
Area of Science:
- Genetics and Molecular Biology
- Neuroscience
- Bioinformatics
Background:
- Huntington's disease (HD) is an inherited neurodegenerative disorder caused by a CAG expansion in the Huntingtin (HTT) gene.
- The precise pathogenesis of HD, despite its monogenic origin, remains incompletely understood.
- Identifying molecular patterns, such as microRNA (miRNA) involvement, is crucial for understanding HD progression.
Purpose of the Study:
- To identify a synergistic microRNA (miRNA) expression pattern associated with Huntington's disease (HD).
- To explore the potential role of identified miRNAs and their target genes in HD pathogenesis.
- To investigate potential therapeutic targets for HD based on miRNA-mRNA interactions.
Main Methods:
- Downloaded and analyzed miRNA (GSE64977) and gene expression (GSE64810) datasets.
- Utilized R programming for identifying differentially expressed genes (DEGs) and differentially expressed miRNAs (DEMs).
- Employed TargetScan for miRNA target prediction, FunRich for Gene Ontology (GO) analysis, and Cytoscape for network construction.
Main Results:
- Identified 1,612 DEGs and 10 DEMs.
- GO analysis of DEGs highlighted roles in inflammatory and immune responses.
- A network analysis revealed 33 overlapping genes between DEM targets and DEGs, implicating hsa‑miR‑4488, hsa‑miR‑196a‑5p, and hsa‑miR‑549a.
Conclusions:
- The study successfully identified a miRNA-mRNA interaction network relevant to HD pathogenesis.
- Specific miRNAs, including hsa‑miR‑4488, hsa‑miR‑196a‑5p, and hsa‑miR‑549a, are implicated in HD.
- These findings suggest potential novel therapeutic targets for Huntington's disease.
Abstract:
Huntington's disease (HD) is an inherited, progressive neurodegenerative disease caused by a CAG expansion in the Huntingtin (HTT) gene and various dysfunctions of biological processes in HD have been proposed. Although monogenic, the exact pathogenesis of HD currently remains unclear. To identify the synergistic microRNA (miRNA) pattern in HD, the miRNA expression profile dataset GSE64977 and the gene expression profile dataset GSE64810 were downloaded. Programming software R was used to identify differentially expressed genes (DEGs) and differentially expressed miRNAs (DEMs). Target genes of DEMs were predicted using the TargetScan database. Gene ontology (GO) function of DEGs was generated using the FunRich and a miRNA‑mRNA interaction network was constructed using Cytoscape software. In total, 1,612 DEGs and 10 DEMs were identified. GO terms mainly included inflammatory response and immune response in DEGs. A total of 745 target genes were predicted from the DEMs and 33 overlaps were identified between these target genes and DEGs. The miRNA network demonstrated that hsa‑miR‑4488, hsa‑miR‑196a‑5p, and hsa‑miR‑549a had a high degree and may be involved with the pathogenesis and potential therapeutic targets of HD.
Related Concept Videos
MicroRNAs
MicroRNAs
Huntington Disease l: Introduction

